Q1 Earnings Snapshot 2026 – Winners, Surprises & Misses Revealed!

Verdict: Strong profit and margin growth, with a sharp QoQ improvement. However, at 93.6x P/E, valuation remains demanding.

Strong Q1 performance with sharp YoY improvement in sales and profitability. However, at 98.4x P/E, valuation remains demanding.

Weak quarter with sharp YoY and QoQ profit decline. Sales declined 6.9% YoY, while EBITDA and Net Profit fell 32.5% and 27.7% YoY respectively. With the stock trading at a high 66.6x P/E, the valuation leaves limited room for execution disappointments.

Mixed/Negative: Sales grew, but sharp EBITDA and net profit declines raise near-term concerns. At 169x P/E, the valuation leaves very little room for earnings disappointment.

Verdict: Profitability rebounded sharply, but revenue remains weak and EBITDA growth is under pressure. At 47.6x P/E, valuation warrants caution.

Strong YoY recovery with a sharp turnaround in profitability and positive EBITDA. QoQ improvement is encouraging, but sustained margins and earnings consistency remain key to watch.

⚠️ Strong sales growth, but the sharp decline in EBITDA and net profit is a clear near-term concern. Valuation remains reasonable, but sustained margin recovery and improvement in profitability will be key triggers for the stock.

Revenue grew 9% YoY and profit nearly doubled, but the sharp QoQ decline in EBITDA and net profit remains a concern. At a P/E of 155.9x, the valuation looks demanding, so fresh entry needs caution.

Revenue grew 9% YoY, but profitability remained under pressure, with EBIDT down 8% and net profit down 26% YoY. QoQ improvement is positive, but earnings recovery is still incomplete.

Verdict: Mixed — monitor for sustained margin and profit recovery.

🟢 Strong quarter: Rubicon Research delivered robust revenue and profit growth, with healthy sequential improvement across key metrics. However, at 93x P/E, the valuation remains demanding; further upside will require sustained high growth and continued earnings momentum.